#AI and #digitaltransformation will be engines of innovation for #lifesciences companies going forward — Here are 3 ways to gain a competitive edge. bit.ly/3JEJZLV

In the spirit of transparency, we’re thrilled to share a report on how we are driving EDI&A and where we are seeing change. Download your own copy to take a closer look at what you can do to further the cause at the workplace. bit.ly/3FOEMA0

Racial labels don’t explain biological and genetic diversity but do cause stigma. They belong “in the dustbin of history,” a panel of experts says. bit.ly/42IHwbM

While Silicon Valley Bank's failure was contained, its effects on #biotech could still linger. bit.ly/3Zmqvl4

Is your company "healthy" enough to work from home? A health management expert shares best-practices for building balanced remote teams. bit.ly/3Kf1Z0P #lifesciences #WorkFromHome

Is your company "healthy" enough to work from home? A health management expert shares best-practices for building balanced remote teams. bit.ly/3nvPRQ8 #lifesciences

As methods of #data acquisition continue to evolve so too must the talent you need to ensure efficient analysis. Learn how to find the right candidates so you can keep pace in this volatile trial landscape. bit.ly/3Kkn61D #BioPharma

In order to innovate, get comfortable with ambiguity. Check out these tips for #lifesciences leaders on navigating change and discomfort. bit.ly/3nJlG7Y

#Pharma companies have been hesitant to adopt predictive maintenance, but doing so could help save costs and improve efficiency. bit.ly/436Bt0R

Are the rapid changes to #biopharma R&D impacting your #ClinicalTrial pipelines? Learn how people-powered change management can help you weather a volatile landscape. bit.ly/3MlIFAo

#Pharma companies expanded their workforces during the past few boom years, but what can leaders do to manage staffing levels through looming economic uncertainty? bit.ly/3nV8OvR

Processing equipment for cell therapies wasn’t designed with commercial manufacturing in mind. What can #pharma leaders do to break through the bottleneck? bit.ly/3nZUORv

When music becomes medicine... Researchers discover that listening to your favorite tune could help improve medication efficacy. bit.ly/3KRZEYX #LifeSciences

Are you the kind of leader who has trouble letting go of control? Here's how to open your mind to embrace collaboration. bit.ly/3UA7ryS #leadership #lifesciences

Dive into the future of the workplace and discover innovative strategies for overcoming staffing shortages in the cell and gene therapy industry. 🧬 Key insights to help your #LifeSciences organization thrive here 👉 bit.ly/3qIObo2

🔬 Research and Development (R&D) never rests. Midway through the year, what are the biggest priorities in the pharma pipeline? Oncology owns over 40% of new drug candidates, followed by 13.5% of pipeline drugs focused on neurological conditions. bit.ly/44ekvxX

What’s keeping pharma leaders up at night? Right now, the industry’s biggest operational challenges are: 📱data protection 💲energy costs ⬇️ unplanned downtime 🎢process variability bit.ly/3Qqw0yd

After a year of record-low drug approvals, 2023 is shaping up to be a rebound. 📈 To date, the FDA has approved “35 new molecular entities and new therapeutic biological products, plus 10 vaccines, allergenic products, and cell and gene therapies”. bit.ly/3PCDe1r

After a year of record-low drug approvals, 2023 is shaping up to be a rebound. 📈 To date, the FDA has approved “35 new molecular entities and new therapeutic biological products, plus 10 vaccines, allergenic products, and cell and gene therapies”. bit.ly/48u76nS

⭐ Our 2024 Salary Guide is here! ⭐ A new year means a new set of national salary trends and insights. Stay ahead of the curve with our 2024 Salary Guide—your key to filling in-demand roles in a competitive market. bit.ly/3Q8Sgfv #RUSASalaryGuide2024